The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States
Christopher R. Flowers(The University of Texas MD Anderson Cancer Center), James R. Cerhan(Mayo Clinic), Giorgio Inghirami(Cornell University), Francisco Vega(The University of Texas MD Anderson Cancer Center), Richard Burack(University of Rochester Medical Center), Carrie A. Thompson(Mayo Clinic), Thomas M. Habermann(Mayo Clinic in Arizona), Karen P. Mann(Emory University), Leon Bernal‐Mizrachi(Emory University), Loretta J. Nastoupil(The University of Texas MD Anderson Cancer Center), John P. Leonard(New York University), Jonathan W. Friedberg(University of Rochester), Peter Martin(Northwestern University), Julianne J. Lunde(Mayo Clinic in Florida), Kathleen J. Yost(Michigan Cancer Research Consortium), Izidore S. Lossos(University of Miami), Matthew J. Maurer(Mayo Clinic in Arizona), Carla Casulo(University of Rochester Medical Center), Susan L. Slager(Mayo Clinic), Brad S. Kahl(UW Health University Hospital), David L. Jaye(Emory University), Brian K. Link(University of Iowa), Timothy J. McDonnell(Health Service Executive), Andrew L. Feldman(Mayo Clinic in Arizona), Sergei Syrbu(University of Iowa), Cristine Allmer(Mayo Clinic in Arizona), Kiran Vij(Washington University in St. Louis)
Cited by 9
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k